1-Methoxy-2-(2-methoxy-ethoxy)-propane | 65624-67-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 1-Methoxy-2-(2-methoxy-ethoxy)-propane
• 英文别名: 1-Methoxy-2-(2-methoxyethoxy)propane
• CAS: 65624-67-1
• 化学式: C₇H₁₆O₃
• 分子量: 148.202
• InChiKey: AVTOLKYEWJVYDR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.2
• 重原子数：
  10
• 可旋转键数：
  6
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  27.7
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  1,5-dibromo-2-methyl-3-oxapentane 、 甲醇 、 氢氧化钾 以44%的产率得到
  参考文献：
  名称：

  MOVSUMZADE M. M.; GURBANOV P. A.; XODZHAEV G. X.; SEIDOV M. A., DOKL. AN AZSSR, 1977, 33, HO 7, 48-52

  摘要：

  DOI：

文献信息

• MATERIAL, METHOD FOR PREPARING SAME, AND USES THEREOF
  申请人：COMMISSARIAT À L'ÉNERGIE ATOMIQUE ET AUX ÉNERGIES ALTERNATIVES

  公开号：US20150057374A1

  公开（公告）日：2015-02-26

  A material including a continuous aqueous phase and a dispersed phase in the form of droplets containing an amphiphilic lipid and a surfactant having the following formula (I): (L 1 -X 1 —H 1 —Y 1 ) v -G-(Y 2 —H 2 —X 2 -L 2 ) w (I), wherein: L 1 and L 2 independently represent lipophilic groups, X 1 , X 2 , Y 1 , Y 2 and G independently represent a linking group, H 1 and H 2 independently represent hydrophilic groups including a polyalkoxylated chain, v and w are independently an integer from 1 to 8, wherein the droplets of the dispersed phase are covalently bonded by the surfactant having the formula (I). The invention also relating to the method for preparing the same and to the uses thereof.

  一种包括连续水相和以含有两性脂质和具有以下式(I)的表面活性剂的液滴形式的分散相的材料： (L1-X1-H1-Y1)v-G-(Y2-H2-X2-L2)w(I)， 其中： L1和L2独立表示亲脂性基团， X1、X2、Y1、Y2和G独立表示连接基团， H1和H2独立表示包括聚烷氧基链的亲水性基团， v和w分别是从1到8的整数， 其中分散相的液滴由具有式(I)的表面活性剂共价结合。该发明还涉及其制备方法和用途。
• Immunogenic composition in emulsion form
  申请人：Commissariat à l'énergie atomique et aux énergies alternatives

  公开号：US10016510B2

  公开（公告）日：2018-07-10

  The present invention relates to an immunogenic composition comprising a continuous aqueous phase and a dispersed phase as droplets and comprising: an amphiphilic lipid, a solubilizing lipid comprising at least one fatty acid glyceride, a co-surfactant comprising at least one chain consisting of alkylene oxide units, a surfactant bearing an antigen of the following formula (I): (L1-X1—H1—Y1)v-G-Z1—Ag  (I), to its preparation method and its uses, notably for producing antibodies, as a drug or in an immunization method.

  本发明涉及一种免疫原组合物，该组合物由连续的水相和作为液滴的分散相组成，并包括 一种两性脂质 一种增溶脂质，由至少一种脂肪酸甘油酯组成、 一种辅助表面活性剂，至少包含一条由环氧亚烷基单元组成的链、 一种含有下式(I)抗原的表面活性剂： (L1-X1-H1-Y1)v-G-Z1-Ag (I)、 及其制备方法和用途，特别是用于生产抗体、作为药物或免疫方法。
• PROCESS FOR PRODUCING BONE GRAFTING MATERIAL, BONE GRAFTING MATERIAL, THREE-DIMENSIONAL SUPPORT FOR CELL CULTURE, AND SEPARATION SUPPORT FOR CHROMATOGRAPHY
  申请人：Tei Yuichi

  公开号：US20100262259A1

  公开（公告）日：2010-10-14

  A novel method for producing a bone filling material is provided. The method comprises the steps of: (a) kneading ingredient comprising calcium-based material and material comprising binder; (b) molding a predetermined shape of the mixture obtained in step (a) with an injection molding machine having a mold; (c) removing the binder contained in the mold formed in step (b) (i.e., degreasing) to obtain a degreased body; (d) and heating and sintering the degreased body obtained in step (c) to obtain a sintered body.
• GEL-FORMING COMPOSITION FOR MEDICAL USE, ADMINISTRATION DEVICE FOR THE COMPOSITION, AND DRUG RELEASE CONTROLLING CARRIER
  申请人：Sasaki Nobuo

  公开号：US20100227804A1

  公开（公告）日：2010-09-09

  It is an object of the present invention to provide a gel-forming composition which permits on-site administration and can form a gel exhibiting prescribed strength and sustained drug release, devices for the administration thereof, and a kit for medical use. A gel-forming composition which is composed of the first composition comprising a drug, a first gelling agent represented by the general formula (I) and the like, and the first diluent and the second composition comprising the second gelling agent represented by the general formula (I) and the like and the second diluent; and application devices and kits for medical use, which can hold the gel-forming composition. X 1 —(OCH 2 CH 2 ) n —X 2 (I) wherein X 1 and X 2 are each —R 1 COONHS (wherein R 1 is C 1-7 alkylene), —COR 1 COONHS, —NOCOR 1 —R 2 (wherein R 2 is maleimido), —R 1 NH 2 , —R 1 SH, or —CO 2 PhNO 2 , and n is an integer of 80 to 1000.
• COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS
  申请人：Bronk Brian Scott

  公开号：US20110251379A1

  公开（公告）日：2011-10-13

  As described herein, the present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.